eagle-i Oregon Health & Science UniversityOregon Health & Science University
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Clinical trial design for retinal degenerative diseases

eagle-i ID


Resource Type

  1. Support service


  1. Resource Description
    "The TCTC RC has gained significant regulatory and organizational experience by being lead participants in ongoing clinical trials. We understand there is a strong need for a reading center that can work with commercial and academic organizations to design clinical trials for retinal disease. Thus, we work with Sponsors to develop standard data analysis requirements for eligibility, treatment criteria and pathological end points. Our team of specialists have extensive experience in Ophthalmological gene therapy trials."
  2. Service Provided by
    Translational Clinical Trials Center Reading Center
  3. Website(s)
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016